Mitchell S. Kapoor Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Mitchell S. Kapoor

Stock Analyst at HC Wainwright & Co.

(4.67)
# 1369
Out of 5,506 analysts
32
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

20 Stocks

Name Action PT Current % Upside Ratings Updated
HALO Halozyme Therapeutic...
Maintains: Strong Buy
85 90
68.98 30.47% 2 Oct 2, 2025
CRSP CRISPR Therapeutics
Reiterates: Buy
80 80
67.74 18.1% 1 Sep 23, 2025
IONS Ionis Pharmaceutical...
Reiterates: Buy
95 95
69.15 37.38% 3 Sep 23, 2025
NTLA Intellia Therapeutic...
Maintains: Strong Buy
25 30
19.96 50.3% 2 Sep 19, 2025
AVTX Avalo Therapeutics
Maintains: Strong Buy
15 25
13.4 86.57% 1 Sep 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
21.43 133.32% 5 Sep 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
125 125
18.1 590.61% 3 Sep 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
60
55.43 8.24% 1 Sep 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.92 27.55% 2 Sep 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 10
5.52 81.16% 1 Aug 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
n/a n/a 2 Aug 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Sell
5 5
22.64 -77.92% 1 Aug 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
13.66 119.62% 1 Aug 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
2.65 164.15% 1 Aug 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 2
3.93 -49.11% 1 Aug 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
n/a n/a 1 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 9
6.62 35.95% 1 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
4.02 248.26% 1 Aug 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 90
46.22 94.72% 1 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 4
1.23 225.2% 1 Aug 11, 2025